Abstract

The research on nervous system diseases is limited by the difficulty in obtaining nerve cells from humans. The development of induced pluripotent stem cells (iPSCs) technology and the experimental system provide a feasible method for directional induced differentiation of nerve cells in vitro. In this project, we recruited a 50-year-old Han Chinese man as a healthy volunteer, and successfully constructed his skin fibroblast-derived iPSCs using the non-integrated reprogramming method. At the same time, the related pluripotency identification experiments were completed. This cell line will be included in the normal control group in follow-up experiments, providing an important reference for the study of neurological diseases.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.